Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Jump to
  • Buy Eris Lifesciences; target of Rs 780: Motilal Oswal Jan 18, 2023 06:07 PM IST

    Buy Eris Lifesciences; target of Rs 780: Motilal Oswal

    Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 780 in its research report dated January 18, 2023.

  • Buy Eris Lifesciences; target of Rs 850: Prabhudas Lilladher Jan 18, 2023 11:34 AM IST

    Buy Eris Lifesciences; target of Rs 850: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated January 18, 2023.

  • Buy Eris Lifesciences; target of Rs 850: Prabhudas Lilladher Oct 25, 2022 02:34 PM IST

    Buy Eris Lifesciences; target of Rs 850: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated October 25, 2022.

  • Buy Eris Lifesciences; target of Rs 825: Prabhudas Lilladher Aug 09, 2022 10:56 AM IST

    Buy Eris Lifesciences; target of Rs 825: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 825 in its research report dated August 08, 2022.

  • Buy Eris Lifesciences; target of Rs 870: Motilal Oswal May 17, 2022 07:59 PM IST

    Buy Eris Lifesciences; target of Rs 870: Motilal Oswal

    Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 870 in its research report dated May 16, 2022.

  • Buy Eris Lifesciences; target of Rs 870: Motilal Oswal May 07, 2022 01:32 PM IST

    Buy Eris Lifesciences; target of Rs 870: Motilal Oswal

    Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 870 in its research report dated May 05, 2022.

  • Buy Eris Lifesciences; target of Rs 850: Prabhudas Lilladher May 07, 2022 09:54 AM IST

    Buy Eris Lifesciences; target of Rs 850: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated May 05, 2022.

  • Buy Eris Lifesciences; target of Rs 870: Motilal Oswal Dec 28, 2021 02:01 PM IST

    Buy Eris Lifesciences; target of Rs 870: Motilal Oswal

    Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 870 in its research report dated December 27, 2021.

  • Buy Eris Lifesciences; target of Rs 954: Prabhudas Lilladher Dec 06, 2021 01:54 PM IST

    Buy Eris Lifesciences; target of Rs 954: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 954 in its research report dated December 06, 2021.

  • Buy Eris Lifesciences; target of Rs 666: Prabhudas Lilladher Feb 05, 2021 08:57 PM IST

    Buy Eris Lifesciences; target of Rs 666: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 666 in its research report dated January 28, 2021.

  • Buy Eris Lifesciences; target of Rs 671: Prabhudas Lilladher Nov 06, 2020 04:39 PM IST

    Buy Eris Lifesciences; target of Rs 671: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 671 in its research report dated November 03, 2020.

  • Buy Eris Lifesciences; target of Rs 576: Prabhudas Lilladher Aug 08, 2020 12:33 PM IST

    Buy Eris Lifesciences; target of Rs 576: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 576 in its research report dated August 05, 2020.

  • Accumulate Eris Lifesciences; target of Rs 576: Prabhudas Lilladher Jun 04, 2020 01:26 PM IST

    Accumulate Eris Lifesciences; target of Rs 576: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 576 in its research report dated Jun 03, 2020.

  • Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher Nov 08, 2019 11:53 AM IST

    Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 459 in its research report dated November 07, 2019.

  • Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher Jul 31, 2019 11:23 AM IST

    Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 459 in its research report dated July 29, 2019.

  • Accumulate Eris Lifesciences; target of Rs 695: Prabhudas Lilladher Jan 30, 2019 12:17 PM IST

    Accumulate Eris Lifesciences; target of Rs 695: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 695 in its research report dated January 29, 2019.

  • Accumulate Eris Lifesciences; target of Rs 704: Prabhudas Lilladher Nov 14, 2018 05:12 PM IST

    Accumulate Eris Lifesciences; target of Rs 704: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 704 in its research report dated November 05, 2018.

  • Accumulate Eris Lifesciences; target of Rs 885: Prabhudas Lilladher Jun 01, 2018 04:31 PM IST

    Accumulate Eris Lifesciences; target of Rs 885: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 885 in its research report dated May 28, 2018.

  • Buy Eris Lifesciences; target of Rs 686: Bonanza Oct 30, 2017 04:34 PM IST

    Buy Eris Lifesciences; target of Rs 686: Bonanza

    Bonanza is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 686 in its research report dated October 26, 2017.

  • Buy Eris Lifesciences; target of Rs 730: Axis Direct Aug 24, 2017 03:11 PM IST

    Buy Eris Lifesciences; target of Rs 730: Axis Direct

    Axis Direct is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 730 in its research report dated 23 August 2017.

  • Is Eris Lifesciences the correct prescription for you? Jun 16, 2017 10:01 AM IST

    Is Eris Lifesciences the correct prescription for you?

    With a predominant focus on the domestic formulations market, a robust portfolio of largely prescription-based drugs, and a tilt towards a promising chronic portfolio, the company seems fundamentally strong.